| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 81 |
| 1 | BROLUCIZUMAB | 48 |
| 2 | RANIBIZUMAB | 18 |
| 3 | BEVACIZUMAB | 16 |
| 4 | ASPIRIN | 12 |
| 5 | ASPIRIN 325 MG | 11 |
| 6 | ASPIRIN 81 MG | 11 |
| 7 | METFORMIN | 11 |
| 8 | PREDNISOLONE | 10 |
| 9 | PREDNISOLONE ORAL | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROLUCIZUMAB | 48 | 0.0132 |
| 1 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 2 | BEPOTASTINE BESILATE | 2 | 0.0031 |
| 3 | TROPICAMIDE | 5 | 0.0031 |
| 4 | AVACINCAPTAD PEGOL | 1 | 0.0028 |
| 5 | AFLIBERCEPT | 81 | 0.0026 |
| 6 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 7 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| 8 | PEGCETACOPLAN | 3 | 0.0016 |
| 9 | TOBRAMYCIN AND DEXAMETHASONE | 5 | 0.0015 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 6 | 0.0014 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 4 | 0.0009 |
| 2 | CD30-directed Immunoconjugate [EPC] | 6 | 0.0006 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 98 | 0.0005 |
| 4 | Photoenhancer [EPC] | 2 | 0.0005 |
| 5 | Anticholinergic [EPC] | 6 | 0.0004 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 7 | 0.0003 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 9 | Anti-anginal [EPC] | 3 | 0.0003 |